Efficacy of L-menthol on Breathlessness in Asthma
- Sponsor
- Region Skane
- Study ID
- NCT07500974
- Phase
- PHASE2
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- L-menthol — DRUG(Sigma-Aldrich, St. Louis, US)
- Placebo — OTHERStrawberry scent (Sigma-Aldrich, St. Louis, US)
Study Details
The purpose of this study is to assess the effect of L-menthol on breathlessness and exercise capacity in patients with Asthma.
Key Dates
- First listed
- Mar 30, 2026
- Start date
- May 7, 2026
- Status verified
- Aug 2026
- Primary completion
- Apr 30, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: L-mentholIn the trial, prior to performing submaximal cardio-pulmonary exercise testing (CPET), participants will be administered, L-menthol patch which will be attached to the inside of a facemask that is connected to the breathing circuit.
- Placebo Comparator: PlaceboFor placebo, the patch will contain a similarly patch with strawberry scent.
Primary Outcome Measure
Breathlessness intensity [ Time Frame: During submaximal test, at isotime during day 2 and day 3. ]
Central Contacts
- Zainab Ahmadi, MD, PhD046171000
Find similar trials
Related Studies
- Role of Genetic Factors in the Development of Lung DiseaseRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Personalized Environment and Genes StudyRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Chapel Hill, North Carolina
- Mechanism(s)of Airflow Limitation in Moderate-severe Persistent AsthmaRecruiting · Gelb, Arthur F., M.D. · Lakewood, California
- Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway InflammationPHASE1 · Recruiting · Benjamin Medoff · Boston, Massachusetts